Abbott chairman and CEO Robert Ford and Taoiseach and leader of Fine Gael Abbott has opened a new manufacturing facility in ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

"DigiCoach program" is a pilot program by Singapore Health Promotion Board, Health2Sync, and Abbott that aims to help individuals with pre-diabetes or high BMI prevent or delay the onset of diabetes.

This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

A continuous glucose monitor is a wearable device that measures blood glucose levels every five minutes, then reports back ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

The most amazing part of being a teacher is witnessing the look on a child’s face when they understand something they thought ...

Historically, providers would need to log into separate portals or support different workflows for each CGM manufacturer to review the data from their patients. Additionally, it was cumbersome to ...

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion.